Cura Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cura Wealth Advisors's LLY Position: Q2 2026 in Review
Cura Wealth Advisors increased its Eli Lilly (LLY) stake by 5.6% in Q2 2026, buying an estimated $32.7K and bringing the position to 602 shares worth $722K. The position accounts for 0.31% of the portfolio, ranked #49.
Cura Wealth Advisors first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $932K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cura Wealth Advisors held 602 shares of Eli Lilly worth $722K as of Q2 2026.
- Cura Wealth Advisors bought 32 Eli Lilly shares in Q2 2026, an estimated $32.7K.
- Eli Lilly made up 0.31% of Cura Wealth Advisors's portfolio in Q2 2026, its #49 holding.
- Cura Wealth Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
- Cura Wealth Advisors's Eli Lilly position peaked at $932K in Q4 2025.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cura Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.